CoChat

Do triglyceride-lowering drugs decrease risk of cardiovascular disease?

Maki, Kevin C., Dicklin, Mary R. · 2017 · Current Opinion in Lipidology

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Purpose of review: This review summarizes the evidence supporting a relationship between lowering triglycerides (TGs) and TG-rich lipoprotein cholesterol (TGRL-C) levels and reduced atherosclerotic cardiovascular disease (ASCVD) event risk. Recent findings: Data from observational investigations, including studies of genetic variants, provide evidence consistent with a causal relationship between elevations in TG and TGRL-C and greater risk for ASCVD. Randomized controlled trial evidence of ASCVD risk reduction with therapies that substantially lower TG and TGRL-C is limited by the fact that no large-scale trial results have been published from a study that enrolled subjects selected specifically on the basis of TG or TGRL-C elevation, although three such trials are underway or in the planning stages. Subgroup analyses from randomized controlled trials are suggestive of a reduction in coronary heart disease and ASCVD event rates with statins, fibrates, omega-3 fatty acid concentrates, and niacin in subjects with elevated TGs, particularly if accompanied by low high-density lipoprotein-cholesterol. Mechanistic studies also support the biologic plausibility of this relationship. Summary: In conclusion, the available data are suggestive of a benefit of ASCVD reduction with therapies that lower TG and TGRL-C; results from ongoing outcomes trials are expected to provide definitive evidence of this relationship.

Overview

Integrity signals

Registry

Crossref · 10.1097/mol.0000000000000424

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 49 references

Cited by

See all 14

Metadata

Authors
Maki, K. C., & Dicklin, M. R.
Affiliations
MB Clinical Research and Consulting (United States) (US)
Corresponding author
Maki, Kevin C.
Venue
Current Opinion in Lipidology
Published
2017-08
Volume
28
Issue
4
Pages
374-379
ISSN
  • 0957-9672 (ISSN-L)
  • 1473-6535
OpenAlex
W2607495523
Cited by
14
References
49
Citations by year
2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 2
FWCI
0.58
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Lipidology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
triglyceride-lowering drugs, atherosclerotic cardiovascular disease, cardiovascular risk reduction, hypertriglyceridemia, statins, fibrates, omega-3 fatty acids, nicotinic acid, low HDL cholesterol, genetic variants, coronary artery disease, randomized controlled trials
MeSH terms
Hypolipidemic Agents, Cardiovascular Diseases, Humans, Risk, Triglycerides, Genetic Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Do triglyceride-lowering drugs decrease risk of cardiovascular disease? https://app.cochat.ai/papers/10.1097/mol.0000000000000424
The paper
Maki, K. C., & Dicklin, M. R. (2017). Do triglyceride-lowering drugs decrease risk of cardiovascular disease? Current Opinion in Lipidology. https://doi.org/10.1097/mol.0000000000000424

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.